Prevalence of human immunodeficiency virus <scp>RNA</scp> and antibody in first‐time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios

Abstract excerpt

BACKGROUND: Twenty-one blood organizations from five geographical regions provided HIV individual donation (ID)-NAT and serology data on 11,787,610 donations. Infections were classified as anti-HIV-/RNA+ window period (WP), anti-HIV+/RNA+ concordant positive (CP) or anti-HIV+/RNA- elite controller (EC). Residual risk and efficacy of several screening scenarios were estimated for first time, lapsed and repeat...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to HIV/AIDS Research and Interventions
• Share to HIV Research and Treatment